← Leaderboards
Peter T Lansbury
Brigham And Women'S Hospital
$7,464,017
Attributed
$7,464,017
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–09$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$24,353,232 · 12
By mechanism
P50$18,545,340 · 4
P01$2,649,696 · 2
R01$2,303,119 · 1
R21$618,812 · 2
R03$172,694 · 1
P41$63,571 · 2
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Jie Shen$46,115,873
- Dennis J Selkoe$33,298,694
- Mel B Feany$26,965,920
- David B. Teplow$13,939,277
- Vikram Khurana$7,485,027
Others in their field
Top investigators on “Alpha Synuclein”
- David A Bennett · Rush University Medical Center$22,290,036
- Joel Synes Perlmutter · Washington University$19,346,398
- John Q. Trojanowski · University Of Pennsylvania$18,630,803
- Robert H Mach · Wake Forest University$18,190,792
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$17,941,681
- Jie Shen · Brigham And Women'S Hospital$16,692,040
Research focus
Alpha SynucleinGene MutationParkinson'S DiseaseAmyloid ProteinsAlzheimer'S DiseaseProtein Structure FunctionMolecular Assembly /Self AssemblyAtomic Force MicroscopyBaseNeurofibrillary TanglesPolymerizationPathogenesisUbiquitinEnzyme StructurePharmaceutical PreparationsPathway InteractionsLewy BodyEsteraseDisease /Disorder OnsetDrosophila GenusParkinsonian DisordersGenetic DisorderCombinatorial ChemistryParkin Gene/Protein
Grant awards (55)
Familial Parkinson's Disease: Clues to Pathogenesis$1,551,940
P50 · FY2009 · NS · contact PI
Biochemistry of PD gene products$388,034
P50 · FY2009 · NS · contact PI
Facility for drug testing in alpha-syn transgenic drosophila & new models of PD$86,936
P50 · FY2009 · NS · contact PI
Administrative Core$37,268
P50 · FY2009 · NS · contact PI
Familial Parkinson's Disease: Clues to Pathogenesis$1,505,718
P50 · FY2008 · NS · contact PI
Biochemistry of PD gene products$376,476
P50 · FY2008 · NS · contact PI
Facility for drug testing in alpha-syn transgenic drosophila & new models of PD$84,350
P50 · FY2008 · NS · contact PI
Administrative Core$36,159
P50 · FY2008 · NS · contact PI
Familial Parkinson's Disease: Clues to Pathogenesis$1,504,613
P50 · FY2007 · NS · contact PI
Biochemistry of PD gene products$391,791
P50 · FY2007 · NS · contact PI
Facility for drug testing in alpha-syn transgenic drosophila & new models of PD$87,765
P50 · FY2007 · NS · contact PI
Administrative Core$37,615
P50 · FY2007 · NS · contact PI
Familial Parkinson's Disease: Clues to Pathogenesis$1,503,319
P50 · FY2006 · NS · contact PI
Biochemistry of PD gene products$394,293
P50 · FY2006 · NS · contact PI
Facility for drug testing in alpha-syn transgenic drosophila & new models of PD$88,326
P50 · FY2006 · NS · contact PI
Discovery of highly toxic synuclein sequence variants$85,444
R03 · FY2006 · NS · contact PI
Administrative Core$37,853
P50 · FY2006 · NS · contact PI
Familial Parkinson's Disease: Clues to Pathogenesis$1,457,794
P50 · FY2005 · NS
Amyloid Deposition in Alzheimer's and Related Diseases$410,875
R01 · FY2005 · AG
Biochemistry of PD gene products$382,628
P50 · FY2005 · NS
A High-Throughput Assay-SOD1 Aggregation Inhibitors(RMI)$218,750
R21 · FY2005 · NS
High Throughout Assay to Probe UCH-L1 Ligase Inhibitors$200,031
R21 · FY2005 · NS
Discovery of highly toxic synuclein sequence variants$87,250
R03 · FY2005 · NS
Facility for drug testing in alpha-syn transgenic drosophila &new models of PD$85,713
P50 · FY2005 · NS
Administrative Core$36,733
P50 · FY2005 · NS
FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS$1,133,503
P50 · FY2004 · NS
Amyloid Deposition in Alzheimer's and Related Diseases$410,875
R01 · FY2004 · AG
High Throughout Assay to Probe UCH-L1 Ligase Inhibitors$200,031
R21 · FY2004 · NS
MASS SPECTROMETRY OF UCH-L1$706
P41 · FY2004 · RR
FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS$1,513,192
P50 · FY2003 · NS
Amyloid Deposition in Alzheimer's and Related Diseases$410,875
R01 · FY2003 · AG
FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS$74,546
P50 · FY2003 · NS
FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS$1,438,077
P50 · FY2002 · NS
Amyloid Deposition in Alzheimer's and Related Diseases$410,281
R01 · FY2002 · AG
Structural biology/ biochemistry--alpha synuclein &other PD linked gene products$0
P50 · FY2002 · NS
FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS$1,436,314
P50 · FY2001 · NS
ALZHEIMER AMYLOIDOGENESIS WITH NEW METHODS$979,007
P01 · FY2001 · AG
Amyloid Deposition in Alzheimer's and Related Diseases$407,016
R01 · FY2001 · AG
Structural biology/ biochemistry--alpha synuclein &other PD linked gene products$248,088
P50 · FY2001 · NS
ATOMIC FORCE MICROSCOPY FOR ANALYSIS OF AMYLOIDOGENESIS$216,966
P01 · FY2001 · AG
FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS$100,000
P50 · FY2001 · NS
IN VITRO FIBRIL FORMATION BY MUTANT ALPHA SYNUCLEIN: PARKINSON DISEASE$53,566
P41 · FY2001 · RR
Structural biology/ biochemistry--alpha synuclein &other PD linked gene products$0
P50 · FY2001 · NS
FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS$1,444,602
P50 · FY2000 · NS
ALZHEIMER AMYLOIDOGENESIS WITH NEW METHODS$952,090
P01 · FY2000 · AG
Structural biology/ biochemistry--alpha synuclein &other PD linked gene products$294,553
P50 · FY2000 · NS
Structural biology/ biochemistry--alpha synuclein &other PD linked gene products$294,553
P50 · FY2000 · NS
AMYLOID DEPOSITION IN ALZHEIMER'S DISEASE$253,197
R01 · FY2000 · AG
Structural biology/ biochemistry--alpha synuclein &other PD linked gene products$248,088
P50 · FY2000 · NS
ATOMIC FORCE MICROSCOPY FOR ANALYSIS OF AMYLOIDOGENESIS$234,667
P01 · FY2000 · AG
ATOMIC FORCE MICROSCOPY FOR ANALYSIS OF AMYLOIDOGENESIS$216,966
P01 · FY2000 · AG
FAMILIAL PARKINSONS DISEASE: CLUES TO PATHOGENESIS$169,500
P50 · FY2000 · NS
FAMILIAL PARKINSON'S DISEASE: CLUES TO PATHOGENESIS$75,000
P50 · FY2000 · NS
ALZHEIMER AMYLOIDOGENESIS WITH NEW METHODS$50,000
P01 · FY2000 · AG
IN VITRO FIBRIL FORMATION BY MUTANT ALPHA SYNUCLEIN: PARKINSON DISEASE$9,299
P41 · FY2000 · RR